A pharmaceutical company fined 50,000 yuan for its unqualified properties of Drynaria fortunei

On February 18, the Sichuan Food and Drug Administration announced information on an administrative penalty decision.

The following is an excerpt:

Sichuan Jingxin Chinese Medicine Pieces Co.

Types of violations

Manufacture and sales of inferior medicine Rhizoma Drynariae (Rich Rhizoma Drynariae) and fail to comply with the drug production quality management regulations

Illegal facts

The batch number 190422-1 of the Chinese medicine Rhizoma Drynariae (Bon Rhizoma Rhizoma Drynariae) produced and sold by the parties was sampled and the test items [Properties] did not meet the requirements.

During the supervision and inspection, it was discovered that the air conditioner of ordinary decoction pieces had no status card, etc.

Basis for punishment

According to Article 74 of the "Drug Administration Law" (revised in 2015) and Article 126 of the "Drug Administration Law" (revised in 2019) and Article 23 of the "Administrative Punishment Law" (revised in 2017) , Article 27, paragraph 1

Penalty content

1.

2.

3.

4.

The total amount of fines and confiscated is 52580.